Related Experiment Video
Updated: May 22, 2025

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
Extreme multivalency and a composite short linear motif facilitate PCNA-binding, localisation and abundance of p21
Signe Simonsen1,2,3, Fia B Larsen2,3, Caroline K Søgaard4
1Structural Biology and NMR Laboratory, Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Denmark.
Abstract:
Cyclin-dependent kinase inhibitor 1 (CDKN1A; also known as p21) promotes cell cycle arrest and regulates DNA replication and DNA repair by high-affinity binding to proliferating cell nuclear antigen (PCNA) using a C-terminal short linear motif (SLiM). High-affinity binding to PCNA is driven by positively charged flanking regions of the SLiM, but the molecular details of their interaction as well as their roles for other p21 functions are not known. Using biophysics to study the interaction between PCNA and p21 variants with different Lys/Arg compositions in the flanking regions, as well as using D-amino acids, we find that the flanking regions of p21 bind to PCNA likely through an interaction driven by complementary charges without specific contacts. Although the exact Lys/Arg composition of the p21 flanking regions is unimportant for high-affinity PCNA binding, these positions are conserved in p21 orthologs, implying a conserved biological function. Accordingly, in cell-based experiments, we find that, while the flanking regions affect p21 abundance, both the context and the Lys/Arg composition of the N-terminal flanking region are crucial for p21 nuclear localisation. Such integration of SLiMs into a composite SLiM may be a widespread phenomenon and complicates the separation of function and drug development.
Insights
Cyclin-dependent kinase inhibitor 1 (CDKN1A) binds to proliferating cell nuclear antigen (PCNA) via a short linear motif. The flanking regions of this motif interact through charge complementarity, influencing p21 abundance and nuclear localization, not just binding affinity.
Area of Science:
- Molecular biology
- Biophysics
- Cell biology
Background:
- Cyclin-dependent kinase inhibitor 1 (CDKN1A; p21) is crucial for cell cycle arrest, DNA replication, and repair.
- p21 interacts with proliferating cell nuclear antigen (PCNA) via a C-terminal short linear motif (SLiM) for high-affinity binding.
- The molecular mechanisms of PCNA-p21 interaction and the role of flanking regions in p21 functions remain largely unknown.
Purpose of the Study:
- To investigate the molecular details of the interaction between PCNA and p21 flanking regions.
- To determine the role of flanking regions' charge composition in PCNA binding and other p21 functions.
- To explore the implications of composite SLiMs for understanding protein function and drug development.
Main Methods:
- Biophysical techniques were employed to study the interaction between PCNA and various p21 variants.
- p21 variants with altered Lys/Arg compositions and D-amino acids in flanking regions were utilized.
- Cell-based experiments assessed p21 abundance and nuclear localization.
Main Results:
- PCNA-p21 flanking region interaction is driven by charge complementarity rather than specific contacts.
- The precise Lys/Arg composition of flanking regions is not critical for high-affinity PCNA binding.
- Flanking regions influence p21 abundance, and their N-terminal context and composition are vital for nuclear localization.
Conclusions:
- The PCNA-binding SLiM of p21 is modulated by flanking regions through charge-based interactions.
- Conserved flanking regions suggest a significant biological role beyond high-affinity binding, impacting p21 localization and abundance.
- The integration of SLiMs into composite motifs presents complexities for functional analysis and therapeutic targeting.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Anaphase Promoting Complex
Positive Regulator Molecules

